New weight loss pill NA-931 tested in obesity trial
Disease control
Not yet recruiting
This study tests an experimental oral drug, NA-931, to see if it helps overweight or obese adults lose weight. Some participants will take NA-931 alone, others will take it with a standard weight-loss injection (tirzepatide), and some will receive a placebo. The study involves 22…
Phase: PHASE2 • Sponsor: Biomed Industries, Inc. • Aim: Disease control
Last updated Apr 30, 2026 15:50 UTC